Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply by Authors.
Agarwal N, McQuarrie K, Bjartell A, Chowdhury S, Pereira de Santana Gomes AJ, Chung BH, Özgüroğlu M, Juárez Soto Á, Merseburger AS, Uemura H, Ye D, Given R, Basch E, Miladinovic B, Lopez-Gitlitz A, Chi KN. Agarwal N, et al. Among authors: juarez soto a. J Urol. 2021 Oct;206(4):923. doi: 10.1097/JU.0000000000001841.03. Epub 2021 Jul 23. J Urol. 2021. PMID: 34296946 No abstract available.
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study.
Agarwal N, McQuarrie K, Bjartell A, Chowdhury S, Pereira de Santana Gomes AJ, Chung BH, Özgüroğlu M, Juárez Soto Á, Merseburger AS, Uemura H, Ye D, Given R, Basch E, Miladinovic B, Lopez-Gitlitz A, Chi KN. Agarwal N, et al. Among authors: juarez soto a. J Urol. 2021 Oct;206(4):914-923. doi: 10.1097/JU.0000000000001841. Epub 2021 May 27. J Urol. 2021. PMID: 34039013 Clinical Trial.
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. Among authors: juarez soto a. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Free article. Clinical Trial.
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Agarwal N, McQuarrie K, Bjartell A, Chowdhury S, Pereira de Santana Gomes AJ, Chung BH, Özgüroğlu M, Juárez Soto Á, Merseburger AS, Uemura H, Ye D, Given R, Cella D, Basch E, Miladinovic B, Dearden L, Deprince K, Naini V, Lopez-Gitlitz A, Chi KN; TITAN investigators. Agarwal N, et al. Among authors: juarez soto a. Lancet Oncol. 2019 Nov;20(11):1518-1530. doi: 10.1016/S1470-2045(19)30620-5. Epub 2019 Sep 29. Lancet Oncol. 2019. PMID: 31578173 Clinical Trial.
[Abiraterone in castration resistant prostate cancer.].
Juárez Soto A, Caballero Cobos R, Campanario Pérez R, Saiz Marenco R, Herrera Torres M, Gamaza Martínez R, Amores Bermúdez J. Juárez Soto A, et al. Arch Esp Urol. 2018 Sep;71(8):651-663. Arch Esp Urol. 2018. PMID: 30319125 Free article. Review. Spanish.
High-risk prostate cancer. Optimal treatment. New evidences.
Álvarez-Maestro M, Quesada Olarte J, Gómez Rivas J, Carrión DM, Juarez Soto A, Rios González E, Aguilera Bazan A, Martínez-Piñeiro L. Álvarez-Maestro M, et al. Among authors: juarez soto a. Arch Esp Urol. 2019 Mar;72(2):203-210. Arch Esp Urol. 2019. PMID: 30855022 Free article. English.
Non-metastatic castration-resistant prostate cancer: management recommendations.
Alcaraz Asensio A, Alvarez Ossorio JL, Cozar Olmo JM, Chantada Abal V, Juarez Soto A, Linares Espinos E, Moreno Jimenez J, Muñoz Rodriguez J, Perez Fentes D, Plata Bello A, Rodrigo Aliaga M, Unda Urzaiz M, Vilaseca A. Alcaraz Asensio A, et al. Among authors: juarez soto a. Actas Urol Esp (Engl Ed). 2022 May;46(4):193-213. doi: 10.1016/j.acuroe.2021.11.001. Epub 2022 Mar 16. Actas Urol Esp (Engl Ed). 2022. PMID: 35305957 Review. English, Spanish.
Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis.
Rodriguez-Vida A, Rodríguez-Alonso A, Useros-Rodríguez E, Lopez-Campos F, Amor-Carro O, Arribas-Ruiz A, Martinez-Torres J, Roca-Pardiñas J, Quesada-García A, Muñoz-Del-Toro JR, Juárez-Soto Á. Rodriguez-Vida A, et al. Among authors: juarez soto a. Clin Genitourin Cancer. 2022 Apr;20(2):197.e1-197.e10. doi: 10.1016/j.clgc.2021.11.008. Epub 2021 Nov 21. Clin Genitourin Cancer. 2022. PMID: 34920959 Free article. Review.
44 results